Cantor Fitzgerald analyst Joseph France noted that it has been reported that UnitedHealth (UNH) is terminating its contract with Envision Healthcare (EVHC) because of alleged deficiencies in the latter's billing practices. He sees this as "particularly damaging" to Envision, both because of UnitedHealth's importance as a leading insurer and because it is central to Envision's effort to convert more of its business in-network. The analyst, who said client turnover could be a headwind for Envision in 2018-19, maintains his Neutral rating on the stock.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Biohaven Pharmaceutical... To see the rest of the story go to thefly.com. See Story Here

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here